Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 150 for “"Allosteric modulator"”.
-
Functional characterization of a novel NMDA receptor positive allosteric modulator
… by low specificity and efficacy. Specific allosteric modulation of NMDA receptors is an ideal solution, but until recently, no known drugs were capable of doing so. Building off previous work in our lab that discovered a novel family of compounds capable of modulating NMDA receptor activity …
-
A Novel Positive Allosteric Modulator of GluN1/3 NMDA Receptors
… of action for AIMS-129 as a novel positive allosteric modulator (PAM) of GluN1/3A and GluN1/3B receptors, with EC50 values of 15 μM and 18 µM, respectively. AIMS-129 maximally potentiates GluN1/3A and GluN1/3B receptors to 214% and 479%, respectively, compared to responses from glycine …
-
A Novel Positive Allosteric Modulator of GluN1/3 NMDA Receptors
… of action for AIMS-129 as a novel positive allosteric modulator (PAM) of GluN1/3A and GluN1/3B receptors, with EC50 values of 15 μM and 18 µM, respectively. AIMS-129 maximally potentiates GluN1/3A and GluN1/3B receptors to 214% and 479%, respectively, compared to responses from glycine …
-
Pharmacology of a novel biased allosteric modulator for NMDA receptors
… approach to regulate NMDAR receptors is thorough allosteric modulators that could allow cell type or circuit-specific modulation, due to widely distributed GluN2 expression, without global NMDAR overactivation59,65,122. In one study, we hypothesized that the compound CNS4 selectively modulates …
-
Evaluating a Positive Allosteric Modulator Radiotracer Candidate to Image the Dopamine D1 Receptor
… suboptimal target selectivity. However, positive allosteric modulators (PAMs) display non-orthosteric binding, theoretically reducing off-target signals. Among such compounds, ASP4345 was examined in preliminary clinical trials and showed activity at rodent and human receptors. Thus, we aim to …
-
Allosteric Modulator of Mas-Related G-Protein Coupled Receptor X1 (MrgprX1) Inhibits Persistent Pain
… allowed us to characterize a potent positive allosteric modulator of MrgprX1, ML382. Cellular studies in humanized MrgprX1 mice suggest that ML382 enhances the ability of bovine adrenal medulla peptide (BAM22, or BAM8–22) as the orthosteric agonist to inhibit N-type voltage-activated calcium …
-
Hydrogen Sulfide as an allosteric modulator of ATP sensitive potassium channels in colonic inflammation.
… These data suggest that NaHS can act as an allosteric modulator for LEV-induced KATP currents. Decreased colonic motility may result from enhanced KATP activation by increased release of H2S in colitis.
-
Structure-activity relation of ivermectin: a Positive Allosteric Modulator of the human P2X4 receptor
Ivermectin (IVM) is as a positive allosteric modulator of the P2X4 receptor, a ligand-gated ion channel activated by ATP. Various features restrict IVM as a viable pharmacological tool for P2X4 receptor modulation, including its ability to bind and modulate other mammalian ion channels. Moreover, …
-
Pharmacological and Pharmacokinetic Studies of a K<sub>Ca</sub>2.2 Positive Allosteric Modulator
… KCa2.2_WT channel rescued by a KCa2.2 positive modulator. A positive allosteric modulator of KCa2.2/KCa2.3 channels (compound 2q) has been developed, and a method for quantitating it in mouse plasma has been validated using FDA guidelines. The developed assay is suitable for preclinical …
-
In vivo effects of the CB1 allosteric modulator LDK1258, a structural analog of ORG-27569
CB1 receptor allosteric modulators are an area of growing interest for their potential novel therapeutic actions. In the present study, we examined LDK1258 in a series of pharmacological in vivo tests sensitive to CB1 receptor stimulation. In the tetrad assay, LDK1258 produced significant decreases …
-
Effects of a metabotropic glutamate receptor 5 positive allosteric modulator, CDPPB, on spatial learning in rodents
… present studies used an mGlu5 receptor positive allosteric modulator, 2-cyano-N-(1,3 diphenyl-1H-hyrazol-5-yl)benzamide (CDPPB) to characterize the importance of mGlu5 receptors in aversively- and appetitively-motivated spatial learning. CDPPB, administered prior to 5 daily training sessions in …
-
Role of Microglial α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator in Neuroinflammatory Pain Models in Mice
… hypothesized that microglial α7 nAChRs positive allosteric modulation in the hippocampus will decrease neuroinflammatory pain at behavioral, cellular, biochemical, and molecular level. The primary objective of current study was to examine the role of an α7 nAChR positive allosteric modulator …
-
Role of Microglial α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator in Animal Model of Major Depressive Disorder
… hypothesized that microglial α7 nAChRs positive allosteric modulator (PAM) has an important role in the regulation of behavioral, cellular, biochemical and molecular mechanisms underlying MDD associated with neuroinflammation in the hippocampus and prefrontal cortex. The primary goal of this …
-
Characterizing the cognitive, behavioural, and mechanistic actions of novel allosteric modulator PAOPA for the treatment of schizophrenia
… evaluate a new drug candidate. PAOPA is a novel allosteric modulator that increases dopamine binding to the dopamine D2 receptor. It has previously shown positive findings in preventing and reversing behaviours proposed to model phenotypes of schizophrenia. However, it has not yet been tested to …
-
Investigation of the allosteric pharmacology of the 5-HT\(_3\) receptor identifying the potent allosteric modulator 5-chloroindole
… indication. The 5-HT\(_3\) receptor is modulated allosterically by various compounds including colchicine, alcohols and volatile anaesthetics but as yet, these modulators either lack potency or selectivity, which hinders investigation. The present study reports a novel 5-HT\(_3\) receptor …
-
Testing the efficacy of LSN2463359, a metabotropic glutamate 5 receptor positive allosteric modulator, in animal models of schizophrenia
… of the metabotropic glutamate 5 receptor modulator LSN2463359, previously shown to act as an indirect agonist of the NMDA receptor, in two different animal models of schizophrenia. Our study found that when LSN2463359 was administered to rats given SDZ 220-581 (an NMDA antagonist) levels …
-
The effect of mGluR2 3 agonist, LY379268, and a mGluR4 positive allosteric modulator, VU0155041, on conditioned taste aversion
… (VU0155041), a mGlu4 receptor selective positive allosteric modulator, on the acquisition of CTA using male Sprague-Dawley rats. It was found that systemic injections of LY379268 prior to the conditioning trial decreased the acquisition of CTA on later test trials, while injections of VU0155041 …
-
Selective modulation of estrogen receptors : 27-hydroxycholesterol is a negative allosteric modulator of er-beta activity and estradiol binding
… (>10-fold). We found that 27-OHC is a negative allosteric modifier of 17{beta]-estradiol binding to ER[beta], with a physiologically relevant Ki of 50nM and cooperativity factor ([alpha]) of 0.036. We also proposed a 3D in silico model of combined docking attempts with 27-OHC in the orthosteric …
-
Neuroprotective Effect of an Α-7 Nicotinic Acetylcholine Receptor Agonist and a Positive Allosteric Modulator in an In Vitro Model of Glaucoma
… α7 nAChR agonist was combined with a positive allosteric modulator (PAM) in dissociated adult porcine retinas to evaluate its effect on isolated RGCs and identify a potential molecular signaling pathway of neuroprotection. Porcine retinas were dissociated using a two-step panning technique to …
-
The CB1 Receptor Positive Allosteric Modulator, ZCZ011, Attenuates Naloxone-Precipitated Withdrawal Signs in Oxycodone-Dependent Mice and Inhibits Small Intestinal Transit in Mice
… side effects is needed. CB1 receptor positive allosteric modulators (PAMs) target and bind to a topographically distinct site, i.e., an allosteric site, that is less conserved than the prototypical orthosteric site where THC, other synthetic cannabinoids (i.e., CP55,940), and the …
Page 1 of 8